Cited by 463PI3K/AKT/mTOR signaling in cancerCancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

A Novel Hypoxia-inducible Factor-independent Hypoxic Response Regulating Mammalian Target of Rapamycin and Its Targets

Open access
Arsham, Andrew M., Howell, Jessica J., Simon, M.Celeste·2003·Journal of Biological Chemistry

Abstract

Hypoxia triggers a reversible inhibition of protein synthesis thought to be important for energy conservation in O2-deficient environments. The mammalian target of rapamycin (mTOR) pathway integrates multiple environmental cues to regulate translation in response to nutrient availability and stress, suggesting it as a candidate for O2 regulation. We show here that hypoxia rapidly and reversibly triggers hypophosphorylation of mTOR and its effectors 4E-BP1, p70S6K, rpS6, and eukaryotic initiation factor 4G. Hypoxic regulation of these translational control proteins is dominant to activation via multiple distinct signaling pathways such as insulin, amino acids, phorbol esters, and serum and is independent of Akt/protein kinase B and AMP-activated protein kinase phosphorylation, ATP levels, ATP:ADP ratios, and hypoxia-inducible factor-1 (HIF-1). Finally, hypoxia appears to repress phosphorylation of translational control proteins in a manner analogous to rapamycin and independent of phosphatase 2A (PP2A) activity. These data demonstrate a new mode of regulation of the mTOR pathway and position this pathway as a powerful point of control by O2 of cellular metabolism and energetics.

Integrity signals

Registry

Crossref · 10.1074/jbc.m212770200

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inactivating mutations in PTEN or TSC, as well as activating mutations in PI3K or AKT, lead to increased TORC1 activity that promotes HIF-α stabilization.

    “Inactivating mutations in phosphatase and tensin homolog (PTEN) or the tuberosis sclerosis complex (TSC) complex, as well as activating mutations in phosphatidylinositol 3-kinase (PI3K) or AKT, lead to increased TORC1 activity that promotes HIF-α stabilization”

    From Hypoxic control of metastasis (2016) · cites this paper as [29]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Arsham, A. M., Howell, J. J., & Simon, M. C.
Affiliations
Howard Hughes Medical Institute (US)
Corresponding author
Simon, M.Celeste
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2003-08
Volume
278
Issue
32
Pages
29655-29660
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1972558089
Cited by
463
References
65
Citations by year
2026: 1 · 2025: 10 · 2024: 9 · 2023: 16 · 2022: 15 · 2021: 18 · 2020: 13 · 2019: 23 · 2018: 20 · 2017: 17 · 2016: 25 · 2015: 26 · 2014: 20 · 2013: 18 · 2012: 18
FWCI
8.54
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
U.S. Public Health Service (63310)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
hypoxia, mTOR signaling, hypophosphorylation, translational regulation, 4E-BP1, p70S6K, ribosomal protein S6, eIF4G, protein synthesis inhibition, oxygen regulation, rapamycin, energy metabolism
MeSH terms
Adenosine Diphosphate, Adenosine Triphosphate, Hypoxia, Carrier Proteins, Cell Line, DNA-Binding Proteins, Dose-Response Relationship, Drug, Gene Expression Regulation, Humans, Nuclear Proteins, Oxygen, Phosphoproteins, Phosphorylation, Protein Kinases, Time Factors, Transcription Factors, Protein Biosynthesis, Blotting, Western, Signal Transduction, Cell Cycle Proteins, Ribosomal Protein S6, Ribosomal Protein S6 Kinases, 70-kDa, Eukaryotic Initiation Factor-4G, Adaptor Proteins, Signal Transducing, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review